Parkinsons Disease

Papers
(The median citation count of Parkinsons Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The Rehabilitative Effect of Archery Exercise Intervention in Patients with Parkinson’s Disease14
A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease11
Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease7
Determining Medication Adherence in Patients Treated for Parkinson’s Disease and Related Factors7
Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies7
Cinnamaldehyde Attenuates the Expression of IBA1 and GFAP to Inhibit Glial Cell Activation and Inflammation in the MPTP‐Induced Acute Parkinson’s Disease Model7
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods7
EMPOWER‐PD: Evaluation of an 8‐Week Co‐Designed Self‐Management Program in People With Parkinson’s Disease and Their Caregivers: An Intervention Study With Long‐Term Follow‐Up7
Method of Tremor Levodopa Responsiveness Assessment and Its Correlation With Clinical Factors in Parkinson’s Disease: Outcomes of the Acute Levodopa Challenge Test7
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk6
Association between Cognitive Impairment and Hippocampal Subfield Volumes in Multiple System Atrophy6
Improvement by Medication Less than Expected in Parkinson’s Disease: Blinded Evaluation of Levodopa Response6
Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease6
Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang5
Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features4
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease4
Quantitative Analysis of Postural Balance in Faller and Nonfaller Patients with Parkinson’s Disease4
Genome‐Wide Association Studies Data and Transcriptomics Data Link Herpes Simplex Virus 1 Infection and Parkinson’s Disease4
The Role of Muscle Strength in the Sit-to-Stand Task in Parkinson’s Disease3
Views and Experiences of Online Exercise Groups for People With Parkinson’s Disease: A Qualitative Study3
Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function3
Qualitative Analysis of Attitudes, Knowledge, and Interest in Research of People with Parkinson’s Disease and Their Care Partners Receiving Accessible Research Education2
Orthostatic Hypotension Is a Predictor of Fatigue in Drug-Naïve Parkinson’s Disease2
Research Participation Among American Indian and Alaskan Native Individuals Living With Parkinson’s Disease2
Patient‐Reported Outcomes of Rotigotine in Parkinson’s Disease: Real‐World Evidence on Symptom Control and Quality of Life From China2
Levodopa Prescription Patterns in Patients with Advanced Parkinson’s Disease: A Japanese Database Analysis2
The Relationship between Visual-Evoked Potential and Optic Coherence Tomography and Clinical Findings in Parkinson Patients2
Exploring the Caregiver Role after Deep Brain Stimulation Surgery for Parkinson’s Disease: A Qualitative Analysis2
Construction and Identification of Inflammation‐Related TF–mRNA–miRNA Coexpression Network and Immune Infiltration in Parkinson’s Disease2
Daily Fluid Intake in People With Newly Diagnosed Parkinson’s Disease Is Reduced Compared With Controls2
Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group2
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review2
Efficacy and Feasibility of Remote Cognitive Remediation Therapy in Parkinson’s Disease: A Randomized Controlled Trial2
Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson’s Disease2
Towards a Biologically Defined Diagnosis: Incorporating Pathophysiological Measures Into Parkinson’s Disease Clinical Criteria1
Factors Influencing Pain Management Practices in People With Parkinson’s Disease: A Qualitative Descriptive Study1
Supplementary Motor Area Activity Differs in Parkinson’s Disease with and without Freezing of Gait1
Single-Cell Analyses Reveal Necroptosis’s Potential Role in Neuron Degeneration and Show Enhanced Neuron-Immune Cell Interaction in Parkinson’s Disease Progression1
Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkisnsonism1
Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study1
1
Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression1
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials1
Diagnostic Accuracy of Machine Learning‐Assisted MRI for Mild Cognitive Impairment in Parkinson’s Disease: A Systematic Review and Meta‐Analysis1
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson’s Disease1
1
Clove Essential Oil Enhances Antioxidant Defenses and Reduces DNA Damage in a Cellular Model of Parkinson’s Disease1
Predictive Value of Brain Volumetry in the Response to Subthalamotomy Using High‐Intensity Focused Ultrasound Treatment in Patients With Parkinson’s Disease1
Feasibility and Acceptability of Intervention and Trial Procedures of the UCL Live Well With Parkinson’s Self‐Management Toolkit1
A Cognitive‐Behavioral Model of Apathy in Parkinson’s Disease1
Mental Fatigue in Parkinson’s Disease: Systematic Review and Evaluation of Self‐Reported Fatigue Scales1
The Use of a Digital Social Forum in a Parkinson’s Disease Risk Cohort: A Thematic Analysis of Forum Messages1
Possible Implications of Managing Alexithymia on Quality of Life in Parkinson’s Disease: A Systematic Review1
Changes in Visual Evoked Potential and Optical Coherence Tomography in Parkinson’s Disease: A Systematic Review and Meta‐Analysis1
The Priority Goals and Underlying Impairments Contributing to Goal-Related Problems of People with Parkinson’s Disease Receiving a Community-Based Rehabilitation Program1
0.10151290893555